Recital 28, Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…

In forcecited 1×

Because the reward is for conducting studies in the paediatric population and not for demonstrating that a product is safe and effective in the paediatric population, the reward should be granted even when a paediatric indication is not authorised. However, to improve the information available on the use of medicinal products in the paediatric population, relevant information on use in paediatric populations should be included in authorised product information.

  • Opinion of Mr Advocate General Bot delivered on 9 June 2011. Merck Sharp & Dohme Corp. v Deutsches Patent- und Markenamt.Decision

    Recitals 26 to 28 to the Paediatric Regulation state: For products falling within the scope of the requirement to submit paediatric data, if all the measures included in the agreed paediatric investigation plan are complied with, if the …

    9 Jun 2011 · 62010CC0125